Bank of New York Mellon Corp
BankPosition in VNDA — Vanda Pharmaceuticals Inc.
CIK 1390777
NEW YORK, NY
Position in VNDA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,039,089
-$143,921 QoQ
Shares Held
169,786
-0.8% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. VNDA ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,039,089 | 169,786 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,183,010 | 171,203 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,514,127 | 171,670 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $896,297 | 179,619 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $820,477 | 173,830 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $786,325 | 171,313 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $838,330 | 175,017 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $962,747 | 205,277 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,457,670 | 257,995 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $975,195 | 237,274 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,076,115 | 255,004 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,078,136 | 249,569 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,443,642 | 522,556 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,469,654 | 510,995 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,736,331 | 505,593 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,544,413 | 763,605 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,720,838 | 616,591 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,467,240 | 1,279,155 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $23,063,762 | 1,469,966 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $22,102,524 | 1,289,529 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 ALXN | — | 1,826,157 | Shares | Defined | 2021-08-11 | |
| 2021-06-30 | $23,503,932 | 1,092,698 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 ALXN | — | 1,813,666 | Shares | Other | 2021-05-13 | |
| 2021-03-31 | $8,791,430 | 585,315 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 ALXN | — | 1,918,977 | Shares | Defined | 2021-02-09 | |
| 2020-12-31 | $7,620,305 | 579,932 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 ALXN | — | 1,773,016 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $5,846,597 | 605,238 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 ALXN | — | 1,679,155 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $7,133,868 | 623,590 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 ALXN | — | 1,661,056 | Shares | Other | 2020-05-06 | |
| 2020-03-31 | $6,221,790 | 600,559 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||